Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Add-on ribociclib continues to triumph in early breast cancer
20 Dec 2023
bởiAudrey Abella
Coming on the heels of the second interim analysis, the protocol-specified final invasive disease-free survival (iDFS) analysis of the phase III NATALEE trial continues to show a highly significant iDFS benefit with the combination of the CDK 4/6 inhibitor ribociclib and a nonsteroidal aromatase inhibitor (NSAI) in individuals with HR+/HER2- early breast cancer.
Add-on ribociclib continues to triumph in early breast cancer
20 Dec 2023
Most HF patients do not undergo loop diuretic dose reduction after SGLT2i initiation
19 Dec 2023
Majority of the patients with heart failure (HF) who have initiated treatment with sodium-glucose cotransporter 2 inhibitor (SGLT2i) show no change in loop diuretic dose, reports a study.
Most HF patients do not undergo loop diuretic dose reduction after SGLT2i initiation
19 Dec 2023
Smartphone-based intervention helps improve mental health of university students
19 Dec 2023
bởiStephen Padilla
Mobile Mindfulness Meditation (MMM) demonstrates effectiveness in reducing stress and anxiety among university students, leading to better mental health, according to a study.
